[1]刘晓龙,李春燕,肖先,等.黄连主要活性成分及药理作用研究进展[J].新乡医学院学报,2023,40(8):784-790.[doi:10.7683/xxyxyxb.2023.08.016]
 LIU Xiaolong,LI Chunyan,XIAO Xian,et al.Research progress on active constituents and pharmacological effect of Coptidis Rhizoma[J].Journal of Xinxiang Medical University,2023,40(8):784-790.[doi:10.7683/xxyxyxb.2023.08.016]
点击复制

黄连主要活性成分及药理作用研究进展
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
40卷
期数:
2023年8
页码:
784-790
栏目:
综述
出版日期:
2023-08-05

文章信息/Info

Title:
Research progress on active constituents and pharmacological effect of Coptidis Rhizoma
作者:
刘晓龙1李春燕12肖先1薛金涛1
(1.新乡医学院药学院,河南 新乡 453002;2.新乡医学院三全学院生物与基础医学实验教学中心,河南 新乡 453003)
Author(s):
LIU Xiaolong1LI Chunyan12XIAO Xian1XUE Jintao1
(1.College of Pharmacy,Xinxiang Medical University,Xinxiang 453003,Henan Province,China;2.Biological and Basic Medical Experimental Teaching Center,Sanquan College of Xinxiang Medical University,Xinxiang 453003,Henan Province,China)
关键词:
黄连化学成分药理作用
Keywords:
Coptidis Rhizomachemical componentpharmacological effect
分类号:
R932
DOI:
10.7683/xxyxyxb.2023.08.016
文献标志码:
A
摘要:
黄连为毛茛科植物黄连、三角叶黄连或云连的干燥根茎。黄连含有生物碱类、木脂素类、黄酮类、酸性成分和挥发油类等多种化学成分,其中最主要的成分是黄连素,又称小檗碱。黄连味苦、性寒,具有清热燥湿、泻火解毒的作用,常用于治疗呕吐吞酸、泻痢、消渴、痈肿疔疮,外治湿疹、湿疮、耳道流脓等。现代药理学研究表明,黄连具有抗心律失常、抗肿瘤、降血糖、抗炎等多种药理作用。本文就黄连的主要活性成分和药理作用进行综述,以期为黄连的开发和临床利用提供参考依据。
Abstract:
Coptidis Rhizoma is the dry rhizome of Coptis chinensis Franch.,Coptis deltoidea C.Y.Cheng et Hsiao or Coptis teeta Wall.of Ranunculaceae.Coptidis Rhizoma contains many chemical components such as alkaloids,lignans,flavonoids,acidic components and volatile oil,among which the most important component is berberine,also known as Berberine Hydrochloride.Coptidis Rhizoma has a bitter taste and a cold nature,and has the effects of clearing heat,drying dampness,purging fire,and detoxifying;it was commonly used to treat vomiting,acid swallowing,diarrhea,thirst,carbuncle and boils,external treatment of eczema,wet sores,ear canal pus,etc.Modern pharmacological research has shown that Coptidis Rhizoma has various pharmacological effects such as anti-arrhythmia,anti-tumor,hypoglycemic,anti-inflammatory,etc.This article reviews the main active constitutents and pharmacological effects of Coptidis Rhizoma,in order to provide reference for the development and clinical application of Coptidis Rhizoma.

参考文献/References:

[1] 付琳,付强,李冀,等.黄连化学成分及药理作用研究进展[J].中医药学报,2021,49(2):87-92.
FU L,FU Q,LI J,et al.Research progress on chemical components and pharmacological effects of Coptis chinensis[J].J Chin Med Pharm,2021,49(2):87-92.
[2] 赵京春.金世元中药材传统鉴别经验 [J].北京中医,2003,22(3):42-43.
ZHAO J C.Jin Shiyuan′s experience on heritable identification the traditional Chinese medicinal materials[J].Beijing J Tradit Chin Med,2003,22(3):42-43.
[3] 徐维相.探讨中药黄连的研究进展[J].世界最新医学信息文摘,2016,16(22):12-13.
XU W X.Research progress on traditional Chinese medicine Huang-lian[J].World Latest Med Inform,2016,16(22):12-13.
[4] 王利红,唐文照,辛义周.黄连中生物碱成分及药理作用研究进展[J].山东中医药大学学报,2015,39(4):389-392.
WANG L H,TANG W Z,XIN Y Z.Research progress on alkaloid components and pharmacological effects in Coptis chinensis[J].J Shandong Univ Tradit Chin Med,2015,39(4):389-392.
[5] WANG L,ZHANG S Y,CHEN L,et al.New enantiomeric isoquinoline alkaloids from Coptis chinensis[J].Phytochem Lett,2014,7:89-92.
[6] YANG T C,CHAO H F,SHI L S,et al.Alkaloids from Coptis chinensis root promote glucose uptake in C2C12 myotubes[J].Fitoterapia,2014,93:239-244.
[7] 李杰,李斌,许彬,等.黄连生物碱提取工艺优化研究[J].中国食品添加剂,2018(6):100-106.
LI J,LI B,XU B,et al.Study on the optimal extraction process of Coptis chinensis franch alkaloids[J].China Food Addit,2018(6):100-106.
[8] 龙成燕,杨炀,黄思行,等.基于高分辨质谱数据库的黄连炮制前后生物碱变化规律[J].中草药,2022,53(19):5972-5979.
LONG C Y,YANG Y,HUANG S X,et al.Changing regularity of alkaloids from Coptis chinensis before and after processing based on HR-MS-Database[J].Chin Tradit Herb Drug,2022,53(19):5972-5979.
[9] FUJIWARA H,NONAKA G,YAGI A,et al.Studies on the components of the leaves of Coptis japonica Makino.I.The structures of coptiside Ⅰ and Ⅱ [J].Chem Pharm Bull (Tokyo),1976,24(3):407-413.
[10] 古丽娜尔·夏依马尔旦.黄连中总黄酮含量测定及提取工艺的研究[J].新疆师范大学学报(自然科学版),2010,29(1):75-78.
GULINAER X.Determination and extraction study on content of total flavones in goldthread[J].J Xinjiang Normal Univ(Nat Sci Edit),2010,29(1):75-78.
[11] 赵薪苑,陈婧,方建国,等.中药和天然药物中黄酮抗病毒活性及其机制研究进展[J].医药导报,2018,37(4):410-415.
ZHAO X Y,CHEN J,FANG J G,et al.Study progress on antiviral activities and mechanisms of flavonoids in traditional Chinese medicine and natural medicines[J].Herald Med,2018,37(4):410-415.
[12] 陈亮,王磊,张庆文,等.黄连非生物碱类化学成分研究[J].中国中药杂志,2012,37(9):1241-1244.
CHEN L,WANG L,ZHANG Q W,et al.Non-alkaloid chemical constituents from Coptis chinensis [J].China J Chin Mater Med,2012,37(9):1241-1244.
[13] 陈国超,李小莉,陈广.黄连中木脂素类化合物的分离鉴定及其对蛋白酪氨酸磷酸酶1B的抑制活性[J].中国药房, 2016,27(16):2197-2200.
CHEN G C,LI X L,CHEN G.Isolation and identification of lignans chemical constituents from Coptis chinensis and their inhibitory activity to protein tyrosine phosphatase-1B[J].China Pharm,2016,27(16):2197-2200.
[14] 黄玲.黄连化学成分及有效成分药理活性的研究进展[J].中西医结合心血管病电子杂志,2020,8(17):136-137.
HUANG L.Research progress on chemical constituents and pharmacological activities of active ingredient of Coptis chinensis[J].Cardiovasc Dis Electr J Integr Tradit Chin Western Med,2020,8(17):136-137.
[15] 贠亚波,杨春雨,郭凤倩,等.姜炙法对寒凉性药挥发油含量及组分的影响[J].中医药信息,2019,36(1):11-16.
YUAN Y B,YANG C Y,GUO F Q,et al.Effect of ginger-processed method on contents and components of volatile oil from herbs with cold feature[J].Inform Tradit Chin Med,2019,36(1):11-16.
[16] WANG J,WANG L,LOU G H,et al.Coptidis Rhizoma:a comprehensive review of its traditional uses,botany,phytochemistry,pharmacology and toxicology[J].Pharm Biol,2019,57(1):193-225.
[17] 刘丹,曹广尚,司席席,等.黄连中生物碱类成分抗心律失常研究概述 [J].山东中医杂志,2017,36(2):164-166,171.
LIU D,CAO G S,SI X X,et al.Overview of research on the antia-rrhythmic effects of alkaloids in Coptis chinensis[J].Shandong J Tradit Chin Med,2017,36(2):164-166,171.
[18] 龚冬梅,单宏丽,周宇宏,等.哇巴因和乌头碱诱发豚鼠和大鼠心律失常的离子作用靶点[J].药学学报,2004,39(5):328-332.
GONG D M,SHAN H L,ZHOU Y H,et al.The ion targets of arrhythmias induced by ouabain and aconitine in guinea pig and rat ventricular myocytes[J].Acta Pharm Sin,2004,39(5):328-332.
[19] YUE P,ZHANG Y,DU Z,et al.Ischemia impairs the association between connexin 43 and M3 subtype of acetylcholine muscarinic receptor (M3-mAChR) in ventricular myocytes[J].Cell Physiol Biochem,2006,17(3/4):129-136.
[20] 冯建平.大剂量黄连素和谷维素及辅酶Q10联用与普萘洛尔治疗心律失常的临床对照研究[J].亚太传统医药,2008,36(8):51-53.
FENG J P.High dose berberine,oryzanol,and coenzyme Q10 A clinical comparative study of propranolol combined with propranolol in the treatment of arrhythmia[J].Asia-Pacific Tradit Med,2008,36(8):51-53.
[21] 蔡芸,信琪琪,高群,等.基于网络药理学研究黄连治疗心房颤动的活性成分及作用机制[J].中西医结合心脑血管病杂志,2019,17(21):3273-3281.
CAI Y,XIN Q Q,GAO Q,et al.Study on active components and mechanism of Coptis chinensis in the treatment of atrial fibrillation based on network pharmacology[J].Chin J Integr Med Cardio-Cerebrovasc Dis,2019,17(21):3273-3281.
[22] 曹新福,李享,刘红旭,等.基于网络药理学的丹皮-赤芍-黄连治疗快速性心律失常的物质基础及作用机制研究 [J].中西医结合心脑血管病杂志,2021,19(10):1601-1609.
CAO X F,LI X,LIU H X,et al.Study on the material basis and molecular mechanism of "Danpi-Chishao-Huanglian" against tachyarrhythmia based on network pharmacology[J].Chin J Integr Med Cardio-Cerebrovasc Dis,2021,19(10):1601-1609.
[23] 刘师序,魏陵博.黄连阿胶汤治疗心系疾病的机制探讨[J].世界最新医学信息文摘,2018,18(A5):248-249.
LIU S X,WEI L B.Mechanism of Huanglian ass hide glue decoction in treating heart diseases[J].World Latest Med Inform,2018,18(A5):248-249.
[24] 张卫娜.黄连温胆汤加减治疗痰火扰心证快速型心律失常的效果及与心电图指标的相关性研究[J].中国医药指南,2021,19(35):120-121,124.
ZHANG W N.Effect of Huanglian Wendan Decoction on tachyarrhythmia of phlegm-fire disturbing heart syndrome and its correlation with ECG indexes[J].Guide China Med,2021,19(35):120-121,124.
[25] 胡茜,张颖,李堃,等.黄连主要成分小檗碱的临床药理作用探析[J].中国中医药现代远程教育,2021,19(24):203-205.
HU X,ZHANG Y,LI K,et al.Analysis of the clinical pharmacological effect of main component berberine in Coptis chinensis[J].Chin Med Mod Dist Educ China,2021,19(24):203-205.
[26] 王晨,陶庆春,娄锡恩.中药治疗糖尿病机制研究进展[J].环球中医药,2022,15(1):152-158.
WANG C,TAO Q C,LOU X E.Progress in research on the mechanism of Chinese medicine in the treatment of diabetes[J].Global Tradit Chin Med,2022,15(1):152-158.
[27] 陈志雄,王晨秀,徐连强,等.黄连素对2型糖尿病早期患者胃肠道激素及糖脂代谢的影响[J].中国当代医药,2021,28(34):120-122,126.
CHEN Z X,WANG C X,XU L Q,et al.Effect of Berberine on gastrointestinal hormones and glucose and lipid metabolism in patients with early type 2 diabetes mellitus[J].China Mod Med,2021,28(34):120-122,126.
[28] SUN H,WANG N,CANG Z,et al.Modulation of microbiota-gut-brain axis by berberine resulting in improved metabolic status in high-fat diet-fed rats[J].Obes Facts,2016,9(6):365-378.
[29] 刘瑾,张美娟,于成兵,等.黄连素对高脂诱导的斑马鱼肝脏细胞脂质代谢的影响[J].水产学报,2022,46(8):1473-1486.
LIU J,ZHANG M J,YU C B,et al.Effects of berberine on lipid metabolism of Danio rerio liver cells induced by high fat[J].J Fish China,2022,46(8):1473-1486.
[30] 郭志利,左晓琦,张梅,等.黄连对2型糖尿病大鼠调节性T细胞及相关炎症因子的影响[J].现代中西医结合杂志,2022,31(5):619-623,717.
GUO Z L,ZUO X Q,ZHANG M,et al.Effect of rhizoma coptidis on regulatory T cells and related inflammatory factors in type 2 dia-betic rats[J].Mod J Integr Tradit Chin West Med,2022,31(5):619-623,717.
[31] 高世勇,石佳,李婉秋,等.黄连解毒汤调节肠道菌群丰度糖尿病研究进展[J].中医学报,2022,37(8):1638-1644.
GAO S Y,SHI J,LI W Q,et al.Huanglian Jiedu Decoction in regulating intestinal flora abundance in treatment of diabetes [J].Acta Chin Med,2022,37(8):1638-1644.
[32] 吴纪,陈泽斌,贺平.炎症反应在肿瘤治疗中的应用[J].热带医学杂志,2022,22(8):1167-1172.
WU J,CHEN Z B,HE P.Application of inflammatory response in tumor therapy[J].J Trop Med,2022,22(8):1167-1172.
[33] 叶姗姗,许超,樊华,等.黄连及其复方在眼科临床应用的研究进展[J].中国中医眼科杂志,2021,31(7):526-529.
YE S S,XU C,FAN H,et al.Clinical application of Rhizoma Coptidis and the compound in ophthalmology[J].J Tradit Chin Ophthalmol,2021,31(7):526-529.
[34] 王佳俊,袁健梅,王立映,等.基于脑肠轴研究黄连厚朴汤治疗小鼠溃疡性结肠炎的作用机制[J].中国中药杂志,2022,47(11):3038-3048.
WANG J J,YUAN J M,WANG L Y,et al.Mechanism of Huanglian Houpo Decoction in treatment of ulcerative colitis in mice based on brain-gut axis[J].China J Chin Mater Med,2022,47(11):3038-3048.
[35] MACIEJ D,SYLWIA Z,AGNIESZKA M,et al.Sanguinarine-chelerythrine fraction of Coptis chinensis exerts anti-inflammatory activity in carrageenan paw oedema test in rats and reveals reduced gastrotoxicity[J].Oxid Med Cell Longev,2022,2022:1504929.
[36] ZHOU J,GU X,FAN X,et al.Anti-inflammatory and regulatory effects of Huanglian Jiedu Decoction on lipid homeostasis and the TLR4/MyD88 signaling pathway in LPS-induced zebrafish[J].Front Physiol,2019,10:1241.
[37] RAM J A.Anti-inflammatory effects of hataedock with coptidis rhizoma and glycyrrhiza uralensis on allergic rhinitis through regulating IL-4 activation[J].J Physiol Pathol Korean Med,2019,33(2):116-122.
[38] 袁远,王璐,庞龙.黄连滴眼液雾化联合复方萘甲唑啉滴眼液对过敏性结膜炎的疗效观察[J].广东医学,2017,38(22):3533-3536.
YUAN Y,WANG L,PANG L.Effect of Coptis chinensis eye drops atomization combined with compound naphazoline eye drops on allergic Conjunctivitis[J].Guangdong Med J,2017,38(22):3533-3536.
[39] 舒智宇.黄连温胆汤联合噻吗洛尔滴眼液治疗青光眼睫状体炎综合征的临床疗效[J].中药药理与临床,2015,31(4):275-277.
SHU Z Y.Analysis of the clinical effects for the patients with glaucomatocy clitic crisis syndrome by Huanglian Wendan Decoction combine with timolol eye drops[J].Pharmocol Clin Chin Mater Med,2015,31(4):275-277.
[40] 隆康健.黄连解毒汤联合头孢曲松钠治疗急性感染性心内膜炎临床研究[J].新中医,2019,51(11):63-66.
LONG K J.Clinical study on Huanglian Jiedu tang combined with ceftriaxone sodium for acute infective endocarditis[J].J New Chin Med,2019,51(11):63-66.
[41] 赵玉泽,王旖,魏志刚,等.黄连素通过调控Caspase-3、Bcl-2表达水平影响肝癌细胞HepG2的增殖和凋亡[J].山西医科大学学报,2022,53(5):509-513.
ZHAO Y Z,WANG Y,WEI Z G,et al.Effects of berberine on proliferation and apoptosis of hepatocellular carcinoma HepG2 cells by regulating Caspase-3 and Bcl-2[J].J Shanxi Med Univ,2022,53(5):509-513.
[42] 闫江娜.黄连增敏肺癌免疫治疗的作用机制研究[D].西安:西北大学,2021.
YAN J N.Study on the mechanism of Huanglian sensitizing immunotherapy for lung cancer[D].Xi′an:Northwest University,2021.
[43] 刘蓉.黄连素抗鼻咽癌细胞转移的作用及机制研究[D].吉首:吉首大学,2021.
LIU R.Study on the anti metastasis effect and mechanism of berberine in nasopharyngeal carcinoma cells[D].Jishou:Jishou University,2021.
[44] 孙强,何曼,张梦,等.小檗碱抗肿瘤作用机制的研究进展 [J].中草药,2021,52(2):603-612.
SUN Q,HE M,ZHANG M,et al.Research progress on anti-tumor effect of berberine[J].Chin Tradit Herb Drug,2021,52(2):603-612.
[45] YONG S,WENTAO W,YUWEN T.Berberine inhibits proliferative ability of breast cancer cells by reducing metadherin[J].Med Sci Monit,2019,25:9058-9066.
[46] PALMIERI A,SCAPOLI L,IAPICHINO A,et al.Berberine and Tinospora cordifolia exert a potential anticancer effect on colon cancer cells by acting on specific pathways[J].Int J Immunopathol Pharmacol,2019,33:2058738419855567.
[47] LIU L,FAN J,AI G,et al.Berberine in combination with cisplatin induces necroptosis and apoptosis in ovarian cancer cells[J].Biol Res,2019,52(1):37.
[48] KIM S Y,PARK C,KIM M Y,et al.ROS-mediated anti-tumor effect of Coptidis Rhizoma against human hepatocellular carcinoma Hep3B cells and xenografts[J].Int J Mol Sci,2021,22(9):4797.
[49] KIM S Y,HWANGBO H,LEE H,et al.Induction of apoptosis by coptisine in Hep3B hepatocellular carcinoma cells through activation of the ROS-mediated JNK signaling pathway[J].Int J Mol Sci,2020,21(15):5502.
[50] 刘明珠,肖贺贺,余庆,等.黄连水提物对卵形鲳鲹源溶藻弧菌的抑菌作用 [J].广西科学院学报,2019,35(2):119-123.
LIU M Z,XIAO H H,YU Q,et al.Antimicrobial effect of water extracts of Coptis chinensis franch against Vibrio alginolyticus from Trachinotus ovatus[J].J Guangxi Acad Sci,2019,35(2):119-123.
[51] 周芳芳,杨温仪,王蕾.黄连解毒汤对100株临床多重耐药菌的体外抑菌效果研究[J].国际检验医学杂志,2018,39(24):3061-3065.
ZHOU F F,YANG W Y,WANG L.In vitro antibacterial effect of coptidis decoction on 100 isolates of multi-drug resistant bacteria [J].Int J Lab Med,2018,39(24):3061-3065.
[52] 吴灵玲,魏敦灿,陈浩浩.盐酸小檗碱和亚胺培南联合作用对耐碳青霉烯类铜绿假单胞菌体外抗菌活性的影响 [J].中国医药科学,2018,8(17):69-72.
WU L L,WEI D C,CHEN H H.Effect of berberine hydrochloride and imipenem on the antibacterial activity of carbapenem resistant Pseudomonas aeruginosa (CPA) in vitro[J].China Med Pharm,2018,8(17):69-72.
[53] 谈丽华.黄连中黄连碱及表小檗碱抗幽门螺杆菌作用机制研究[D].广州:广州中医药大学,2019.
TAN L H.Study on the mechanism of berberine and epi Berberine in coptis chinensis against helicobacter pylori[D].Guangzhou:Guangzhou University of Chinese Medicine,2019.
[54] TSENG C Y,SUN M F,LI T C,et al.Effect of Coptis chinensis on biofilm formation and antibiotic susceptibility in Mycobacterium abscessus[J].Evid Based Complement Alternat Med,2020,2020:9754357.
[55] 邓晗.黄连素对鱼藤酮/MPP+处理的SH-SY5Y细胞以及MPTP制备的帕金森病模型小鼠的保护作用及机制探讨[D].青岛:青岛大学,2020.
DENG H.The protective effects and mechanisms of berberine on rotenone/MPP+-treated SH-SY5Y cells and MPTP-induced Parkinson′s disease in mice[D].Qingdao:Qingdao University,2020.
[56] 李艾芳,陈思宇,黄一丹,等.黄连素联合右美托咪定在急性脑梗死大鼠模型中的协同神经保护作用[J].实用药物与临床,2020,23(9):769-774.
LI A F,CHEN S Y,HUANG Y D,et al.Neuroprotective effect of berberine combined with dexmedetomidine on rat model of acute cerebral infarction[J].Pract Pharm Clin Rem,2020,23(9):769-774.
[57] 郭云良.胡黄连苷Ⅱ对缺血性脑卒中的神经保护机制研究[Z].青岛大学附属医院,2021.
GUO Y L.Study on the neuroprotective mechanism of Hu Huang Lian glycoside Ⅱ on ischemic stroke[Z].Affiliated Hospital of Qingdao University,2019.
[58] 张艳雪.胡黄连苷Ⅱ调节AMPK-mTOR-ULK1自噬信号通路对脑缺血再灌注损伤的保护机制研究 [D].青岛:青岛大学,2019.
ZHANG Y X.Study on the protective mechanism of Huhuanglian glycoside Ⅱ regulating the AMPK-mTOR-ULK1 autophagy signaling pathway against cerebral ischemia-reperfusion injury[D].Qingdao:Qingdao University,2019.
[59] 姜学泽,陈宇涵,陈友铭,等.黄连素下调细胞周期蛋白依赖性激酶-2活性抑制血管紧张素Ⅱ诱导的心肌纤维化 [J].同济大学学报(医学版),2020,41(6):691-699.
JIANG X Z,CHEN Y H,CHEN Y M,et al.Berberine attenuates angiotensin Ⅱ-induced cardiac fibrosis by inhibition of cyclin-dependent protein kinases-2 activity[J].J Tongji Univ (Med Sci),2020,41(6):691-699.
[60] 李君,王倩青,郜智慧,等.胡黄连苷Ⅱ降低M2型巨噬细胞的表达及对子宫内膜异位症大鼠盆腔粘连和内膜细胞凋亡的调节作用[J].免疫学杂志,2020,36(11):994-1000.
LI J,WANG Q Q,GAO Z H,et al.Picroside Ⅱ reduces the expression of M2 macrophages and regulates pelvic adhesion and endometrial cell apoptosis in rats with endometriosis[J].Immunol J,2020,36(11):994-1000.
[61] HU M,WU F,LUO J,et al.The role of berberine in the prevention of HIF-1α activation to alleviate adipose tissue fibrosis in high-fat-diet-induced obese mice[J].Evid Based Complement Alternat Med,2018,2018:4395137.

相似文献/References:

[1]孙 华,李春燕,薛金涛.葛根的化学成分及药理作用研究进展[J].新乡医学院学报,2019,36(11):1097.[doi:10.7683/xxyxyxb.2019.11.022]
[2]迟宇昊,李 暘,申 远.麦冬化学成分及药理作用研究进展[J].新乡医学院学报,2021,38(2):189.[doi:10.7683/xxyxyxb.2021.02.020]
[3]杜晓妍,吴 娇.茯苓的化学成分和药理作用研究进展[J].新乡医学院学报,2021,38(5):496.[doi:10.7683/xxyxyxb.2021.05.022]
[4]冬海洋,李彦灵,马矜烁,等.中药牛膝叶化学成分分析[J].新乡医学院学报,2020,37(1):012.[doi:10.7683/xxyxyxb.2020.01.004]
 DONG Haiyang,LI Yanling,MA Jinshuo,et al.Analysis of chemical constituents of Achyranthes bidentata leaf[J].Journal of Xinxiang Medical University,2020,37(8):012.[doi:10.7683/xxyxyxb.2020.01.004]
[5]吴 娇,王 聪.黄芪的化学成分及药理作用研究进展[J].新乡医学院学报,2018,35(9):755.[doi:10.7683/xxyxyxb.2018.09.002]
 N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(8):755.[doi:10.7683/xxyxyxb.2018.09.002]
[6]殷田田,白意晓,庄方方,等.高莴苣化学成分研究[J].新乡医学院学报,2016,33(2):091.[doi:10.7683/xxyxyxb.2016.02.003]
 YIN Tian-tian,BAI Yi-xiao,ZHUANG Fang-fang,et al.Chemical constituents of Lactuca elata[J].Journal of Xinxiang Medical University,2016,33(8):091.[doi:10.7683/xxyxyxb.2016.02.003]
[7]曹 轲,丁明明,庄方方,等.中药糙苏中的环烯醚萜类化合物[J].新乡医学院学报,2016,33(3):164.[doi:10.7683/xxyxyxb.2016.03.002]
 CAO Ke,DING Ming-ming,ZHUANG Fang-fang,et al.Iridoid compounds from Phlomis umbrosa of herb medicine[J].Journal of Xinxiang Medical University,2016,33(8):164.[doi:10.7683/xxyxyxb.2016.03.002]
[8]刘军伟,吕洁丽,张来宾.山药地上部分石油醚部位的化学成分研究[J].新乡医学院学报,2016,33(6):457.[doi:10.7683/xxyxyxb.2016.06.003]
 LIU Jun-wei,LYU Jie-li,ZHANG Lai-bin.Chemical constituents of the petroleum ether fraction from the aerial part of Dioscorea opposita[J].Journal of Xinxiang Medical University,2016,33(8):457.[doi:10.7683/xxyxyxb.2016.06.003]
[9]周慧超,贺 爽,宋 宇,等.全缘橐吾根部化学成分及生物活性研究[J].新乡医学院学报,2016,33(12):1017.[doi:10.7683/xxyxyxb.2016.12.001]
 ZHOU Hui-chao,HE Shuang,SONG Yu,et al.Chemical constituents and biological activity of Ligularia mongolica root[J].Journal of Xinxiang Medical University,2016,33(8):1017.[doi:10.7683/xxyxyxb.2016.12.001]
[10]兰宝恒,吴泽青.柴胡的化学成分及药理作用研究进展[J].新乡医学院学报,2023,40(2):174.[doi:10.7683/xxyxyxb.2023.02.015]
 LAN Baoheng,WU Zeqing.Research progress on chemical constituents and pharmacological action of Bupleurum[J].Journal of Xinxiang Medical University,2023,40(8):174.[doi:10.7683/xxyxyxb.2023.02.015]

更新日期/Last Update: 2023-08-05